Capital Bank & Trust’s AstraZeneca AZN Stock Holding History

Capital Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-326,217	Closed	-$39.1M	–	23
2021 Q2	$39.1M	Buy	326,217 +1,398	+0.4%	+$153K	0.45%	74
2021 Q1	$32.3M	Sell	324,819 -752	-0.2%	-$75.6K	0.38%	72
2020 Q4	$32.6M	Sell	325,571 -1,677	-0.5%	-$178K	0.4%	74
2020 Q3	$35.9M	Sell	327,248 -5,802	-2%	-$645K	0.48%	62
2020 Q2	$35.2M	Sell	333,050 -22,600	-6%	-$2.33M	0.51%	55
2020 Q1	$31.8M	Buy	355,650 +2,505	+0.7%	+$236K	0.53%	52
2019 Q4	$35.2M	Sell	353,145 -8,125	-2%	-$765K	0.46%	67
2019 Q3	$32.2M	Sell	361,270 -440,709	-55%	-$38.2M	0.45%	67
2019 Q2	$66M	Sell	801,979 -23,841	-3%	-$1.87M	0.81%	52
2019 Q1	$68.9M	Buy	825,820 +20,139	+2%	+$1.59M	0.87%	48
2018 Q4	$61.2M	Sell	805,681 -60,627	-7%	-$4.73M	0.89%	43
2018 Q3	$68.6M	Buy	866,308 +18,225	+2%	+$1.38M	0.85%	42
2018 Q2	$59.6M	Sell	848,083 -29,726	-3%	-$2.14M	0.78%	50
2018 Q1	$61.4M	Buy	877,809 +22,258	+3%	+$1.54M	0.83%	43
2017 Q4	$59.4M	Sell	855,551 -509,553	-37%	-$34.4M	0.81%	47
2017 Q3	$92.5M	Buy	1,365,104 +28,676	+2%	+$1.81M	1.18%	27
2017 Q2	$91.1M	Buy	+1,336,428	New	+$87.3M	1.19%	23

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Bank & Trust's AZN Position: Q3 2021 in Review

Capital Bank & Trust sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 326,217 shares — an estimated $39.1M sold.

Capital Bank & Trust first reported a position in AZN in Q2 2017 and held it in 17 quarters. The position peaked at $92.5M in Q3 2017. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Capital Bank & Trust reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
Capital Bank & Trust sold 326,217 AstraZeneca shares in Q3 2021, an estimated $39.1M.
Capital Bank & Trust first reported a position in AstraZeneca in Q2 2017 and held it in 17 quarters.
Capital Bank & Trust's AstraZeneca position peaked at $92.5M in Q3 2017.
908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.